Skip to main content
Top

Current Atherosclerosis Reports

Issue 3/2015

Content (8 Articles)

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Cardiovascular Prevention in the Cancer Survivor

Carol L. Chen

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Use of Novel Antiplatelet Agents in Acute Coronary Syndromes

Michael Luna, Elizabeth M. Holper

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Available Transcatheter Aortic Valve Replacement Technology

Dillon Weiss, Carlos E. Ruiz, Luigi Pirelli, Vladimir Jelnin, Gregory P. Fontana, Chad Kliger

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Radial Artery Occlusion After Transradial Approach to Cardiac Catheterization

John F. Wagener, Sunil V. Rao

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Drug-Eluting Stents: the Past, Present, and Future

Gregory Katz, Bhisham Harchandani, Binita Shah

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

Role of Non-invasive Imaging in the Work-Up of Cardiomyopathies

Lakshmi S. Tummala, Raymond K. Young, Tania Singh, Sandeep Jani, Monvadi B. Srichai

Coronary Heart Disease (E Gianos and B Shah, Section Editor)

The Role of Testosterone Therapy in Cardiovascular Mortality: Culprit or Innocent Bystander?

Monique S. Tanna, Arthur Schwartzbard, Jeffery S. Berger, Joseph Alukal, Howard Weintraub

Nonstatin Drugs (EM deGoma, Section Editor)

PCSK9 Inhibition: Current Concepts and Lessons from Human Genetics

Fatima Rodriguez, Joshua W. Knowles

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine